CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 15 No. 6
Pages: 1  2  
Next
 

Confocal Laser Endomicroscopy Can Facilitate the Diagnosis of Both Esophageal and Gastric Cancers

June 1, 2006

SAN FRANCISCO—Confocal laser endomicroscopy, a new technology that permits high-resolution subsurface microscopic imaging of living tissue during routine endoscopy, can facilitate the diagnosis of esophageal and gastric cancers, according to a recent report. "Endomicroscopy allows you to make an in vivo histology during ongoing endoscopy," Ralf Kiesslich, MD, PhD, said at the 2006 Gastrointestinal Cancers Symposium (General Session I).

The device used is a conventional endoscope that has a confocal microscope integrated into its distal tip, and buttons on the endpiece that control the depth of the imaging plane, explained Dr. Kiesslich, head of the Endoscopic Unit at the University of Mainz, Germany. "Handling of the endoscope is very similar to a conventional endoscope," he added.

Conventional video endoscopy is always performed first. "Inspection of the surface architecture is mandatory prior to endomicroscopy because you have to choose an area of interest where you would like to perform endomicroscopy," Dr. Kiesslich explained. Once an area of interest has been selected, the endoscope is placed in contact with the mucosa, a blue laser light is emitted, and optical sections are obtained, moving from the surface to deeper layers. The field of view is 500 μm X 500 μm, the optical sections are about 7 μm thick, and imaging is possible to a depth of up to 250 μm below the mucosal surface.

Two contrast agents are commonly used during endomicroscopy to enhance mucosal surface and subsurface structures, Dr. Kiesslich said. One is acriflavine, which is applied topically for imaging in the stomach and colon, and the other is fluorescein(Drug information on fluorescein), which is given intravenously for imaging in the esophagus, stomach, and colon. The images obtained are usually displayed in gray-scale, but color can be added to simulate the normal mucosal appearance.

The learning curve for confocal laser endomicroscopy ranges from 1 week for the imaging of normal tissue to 3 months for the imaging of pathologic tissue, he said. The new technology adds only 10 to 20 minutes to the conventional endoscopy procedure. Although it permits immediate diagnosis at the bedside in some cases, a pathologist is still needed for definitive diagnosis, he emphasized.

Esophageal Applications

In the esophagus, one application of confocal laser endomicroscopy is the diagnosis of Barrett esophagus and associated neoplasia, Dr. Kiesslich said. The new technology permits detailed visualization of the specialized columnar Barrett epithelium, including the glands and individual goblet cells. It can also reveal areas within this epithelium where goblet cells are depleted and where neoplastic epithelial cells have crossed the basement membrane and invaded the lamina propria, both indicators of dysplasia. With the added information from endomicroscopy, he noted, "targeted biopsies can be limited to suspected areas."

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy